The results of a pilot multimodality program (surgery + radiotherapy + chemotherapy) are reported in 34 women with advanced stage I11 and IV adenocarcinoma of the breast. The median relapse-free survival for all patients was 24 months, with 74 % of the premenopausal patients and 37 % of the postmeno
Multimodal approach in the therapy of stage III female breast cancers
โ Scribed by V. Shanta; S. Krishnamurthi; D. V. L. N. Sastry; Ranjini Menon
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 506 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
โฆ Synopsis
One thousand thirty-seven female breast cancers were treated at the Cancer Institute (WIA), Madras, between 1965 and 1978. Five hundred twenty-one of them (ie, just over 50%) were in stage 111, with extensive local disease, unsuitable for surgery ab initio. Four hundred twelve of them (group A) received radiation therapy (RT) initially and 109 (group B) a combination of radiation and chemotherapy (CT). In 68% of the former and 77% of the latter the tumours became resectable after this preliminary treatment. Radical mastectomy in group A and Patey's mastectomy in group B were performed. The material in these two groups was similar. The five-year survival NED in group A was 45 % , and in group B 64.61 % . Adequate surgery following RT and CT seemed essential to improve survival. The impact of added chemotherapy (CT) was mainly felt in the node-positive cases.
๐ SIMILAR VOLUMES
One hundred seventy-four evaluable patients with noninflammatory Stage III (both operable and inoperable) breast cancer were treated with a combined modality strategy between 1974 and 1985. All patients received combination chemotherapy with 5-fluorouracil, Adriamycin (doxorubicin), and cyclophospha
## Abstract Of 606 female breast cancers treated, 364 of them in stage I, II, and III, only 7 cases were in stage I. All stage II and III cases in good general condition received radical preoperative irradiation to the entire breast volume and the regional lymphatic areas over a period of 4 wk, fol